Page 41 - AN-2-3

Advanced Neurology Multiple sclerosis: Immunopathogenesis

Funding https://doi.org/10.1056/NEJMra1401483

None. 8. Stys PK, Tsutsui S, 2019, Recent advances in understanding
multiple sclerosis. F1000Res, 8: 2100.
Conflict of interest https://doi.org/10.12688/f1000research.20906.1

The authors declare that they have no competing interests. 9. Sellebjerg F, Börnsen L, Ammitzbøll C, et al., 2017, Defining
active progressive multiple sclerosis. Mult Scler, 23:
Author contributions 1727–1735.

Conceptualization: All authors https://doi.org/10.1177/1352458517726592
Writing – original draft: Benediktas Trumpulis 10. Pozzilli C, Pugliatti M, Vermersch P, et al., 2023, Diagnosis
Writing – review & editing: Rasa Liutkeviciene, Renata and treatment of progressive multiple sclerosis: A position
Balnyte paper. Eur J Neurol, 30: 9–21.

Ethics approval and consent to participate https://doi.org/10.1111/ene.15593
Not applicable. 11. Ziemssen T, Bhan V, Chataway J, et al., 2023, Secondary
progressive multiple sclerosis: A review of clinical
Consent for publication characteristics, definition, prognostic tools, and disease-
modifying therapies. Neurol Neuroimmunol Neuroinflamm,
Not applicable. 10: e200064.

Availability of data https://doi.org/10.1212/NXI.0000000000200064
12. Thompson AJ, Banwell BL, Barkhof F, et al., 2018, Diagnosis
Not applicable. of multiple sclerosis: 2017 revisions of the McDonald
criteria. Lancet Neurol, 17: 162–173.
References
https://doi.org/10.1016/S1474-4422(17)30470-2
1. Wallin MT, Culpepper WJ, Nichols E, et al., 2019, Global,
regional, and national burden of multiple sclerosis 1990– 13. Goodin DS, Khankhanian P, Gourraud PA, et al., 2021,
2016: A systematic analysis for the Global Burden of Disease The nature of genetic and environmental susceptibility to
Study 2016. Lancet Neurol, 18: 269–285. multiple sclerosis. PLoS One, 16: e0246157.
https://doi.org/10.1016/S1474-4422(18)30443-5 https://doi.org/10.1371/journal.pone.0246157
2. Walton C, King R, Rechtman L, et al., 2020, Rising prevalence 14. Gerdes LA, Janoschka C, Eveslage M, et al., 2020, Immune
of multiple sclerosis worldwide: Insights from the Atlas of signatures of prodromal multiple sclerosis in monozygotic
MS, third edition. Mult Scler, 26: 1816–1821. twins. Proc Natl Acad Sci U S A, 117: 21546–21556.
https://doi.org/10.1177/1352458520970841 https://doi.org/10.1073/pnas.2003339117
3. Leray E, Moreau T, Fromont A, et al., 2016, Epidemiology of 15. Ortega-Hernandez OD, Martínez-Cáceres EM, Presas-
multiple sclerosis. Rev Neurol (Paris), 172: 3–13. Rodríguez S, et al., 2023, Epstein-barr virus and multiple
sclerosis: A convoluted interaction and the opportunity to
https://doi.org/10.1016/j.neurol.2015.10.006 unravel predictive biomarkers. Int J Mol Sci, 24: 7407.
4. Valadkeviciene D, Kavaliunas A, Kizlaitiene R, et al., https://doi.org/10.3390/ijms24087407
2019, Incidence rate and sex ratio in multiple sclerosis in
Lithuania. Brain Behav, 9: e01150. 16. Bjornevik K, Cortese M, Healy BC, et al., 2022, Longitudinal
analysis reveals high prevalence of Epstein-Barr virus
https://doi.org/10.1002/brb3.1150 associated with multiple sclerosis. Science, 375: 296–301.
5. Yong HYF, Yong VW, 2022, Mechanism-based criteria https://doi.org/10.1126/science.abj8222
to improve therapeutic outcomes in progressive multiple
sclerosis. Nat Rev Neurol, 18: 40–55. 17. Kuchroo VK, Weiner HL, 2022, How does Epstein-Barr
virus trigger MS? Immunity, 55: 390–392.
https://doi.org/10.1038/s41582-021-00581-x
https://doi.org/10.1016/j.immuni.2022.02.008
6. Amezcua L, 2022, Progressive multiple sclerosis. Continuum 18. Vasileiou ES, Hu C, Bernstein CN, et al., 2022, Association
(Minneap Minn), 28: 1083–1103.
of Vitamin D polygenic risk scores and disease outcome
https://doi.org/10.1212/CON.0000000000001157 in people with multiple sclerosis. Neurol Neuroimmunol
Neuroinflamm, 10: e20006.
7. Reich DS, Lucchinetti CF, Calabresi PA, 2018, Multiple
sclerosis. N Engl J Med, 378: 169–180. https://doi.org/10.1212/NXI.0000000000200062

Volume 2 Issue 3 (2023) 10 https://doi.org/10.36922/an.1319